These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2490491)

  • 21. Carbapenems, monobactams and quinolones.
    Chambers ST
    N Z Med J; 1989 Jan; 102(860):6-7. PubMed ID: 2536477
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transduction of resistance to Imipenem, Aztreonam and Ceftazidime in nosocomial strains of Pseudomonas aeruginosa by wild-type phages.
    Blahová J; Hupková M; Babálová M; Krcméry V; Schäfer V
    Acta Virol; 1993 Dec; 37(6):429-36. PubMed ID: 8010181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New antibiotics in pediatrics].
    Ruiz Contreras J
    An Esp Pediatr; 1989 Dec; 31(6):515-8. PubMed ID: 2698065
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 28. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1985 Dec; 38(12):3561-72. PubMed ID: 3834139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies on aztreonam following intravenous drip infusion].
    Yoshimoto M; Nakanishi Y; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Shimizu K; Ueda N
    Jpn J Antibiot; 1985 Oct; 38(10):2827-37. PubMed ID: 4078996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of azthreonam in the treatment of severe infections: study of 17 cases].
    León de Lope M; Nogales Pérez MC; Gálvez Acebal J; Mañas Frías R; Perea Pérez EJ; Martínez-Luengas F
    Med Clin (Barc); 1985 Jun; 85(2):58-60. PubMed ID: 4040593
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent progress in antimicrobial agents].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1519-23. PubMed ID: 2854150
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recommendations for the indication-justified use of antibiotics. 1. beta-lactam antibiotics].
    Briedigkeit H; Halle E
    Z Arztl Fortbild (Jena); 1991 Aug; 85(15):698-702. PubMed ID: 1949988
    [No Abstract]   [Full Text] [Related]  

  • 38. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].
    Lipp HP
    Med Monatsschr Pharm; 2012 Oct; 35(10):367-77. PubMed ID: 23094579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of monobactam antibiotics in surgical infections.
    DiPiro JT; Bowden TA
    Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.